Bey, P <br/><br/>
A double-blind, placebo-controlled trial of i.v. dolasetron mesilate in the prevention of radiotherapy-induced nausea and vomiting in cancer patients.  [electronic resource] 

 -  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer  Sep 1996 
 - 378-83 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0941-4355 
<br/><br/><label>Standard No.: </label>10.1007/BF01788845  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Analysis of Variance<br/>Antiemetics--administration & dosage<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Indoles--administration & dosage<br/>Injections, Intravenous<br/>Linear Models<br/>Male<br/>Middle Aged<br/>Nausea--etiology<br/>Neoplasms--pathology<br/>Quinolizines--administration & dosage<br/>Radiotherapy, High-Energy--adverse effects<br/>Treatment Outcome<br/>Vomiting--etiology